Publications

  1. Koster MJ, Warrington KJ. Vasculitis syndromes: Tocilizumab - a new frontier for GCA therapy. Nat Rev Rheumatol. 2017 Dec; 13 (12):700-701 Epub 2017 Sept 07
    View PubMed
  2. Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium. Evaluation of damage in giant cell arteritis. Rheumatology (Oxford). 2017 Nov 03 [Epub ahead of print]
    View PubMed
  3. Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Cikikci C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis. Rheumatology (Oxford). 2017 Nov 01; 56 (11):1939-1944
    View PubMed
  4. Chen JJ, Warrington KJ, Garrity JA, Prasad S. Is Routine Imaging of the Aorta Warranted in Patients With Giant Cell Arteritis? J Neuroophthalmol. 2017 Sep; 37 (3):314-319
    View PubMed
  5. Koster MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, Matteson EL, Warrington KJ. Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study. J Rheumatol. 2017 Jul; 44: (7)1044-1050.
    View PubMed
  6. Koster MJ, Warrington KJ. Classification of large vessel vasculitis: Can we separate giant cell arteritis from Takayasu arteritis? Presse Med. 2017 Jul - Aug; 46 (7-8 Pt 2):e205-e213 Epub 2017 July 31
    View PubMed
  7. Brennan DN, Warrington KJ, Crowson CS, Schmidt J, Koster MJ. Cardiopulmonary involvement in Takayasu's arteritis. Clin Exp Rheumatol. 2017 Jun 12;
    View PubMed
  8. Alibaz-Oner F, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Salvarani C, Matteson EL, Warrington KJ. Clinical Spectrum of Medium-Sized Vessel Vasculitis. Arthritis Care Res (Hoboken). 2017 Jun; 69 (6):884-891 Epub 2017 Apr 24
    View PubMed
  9. Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, Weyand CM. Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients. Mod Pathol. 2017 Jun; 30 (6):788-796 Epub 2017 Mar 03
    View PubMed
  10. Krause ML, Yi ES, Warrington KJ. Pulmonary IgG4-related disease and colon adenocarcinoma: possible paraneoplastic syndrome. Int J Rheum Dis. 2017 May; 20: (5)654-656.
    View PubMed
  11. Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA, Vasculitis Clinical Research Consortium. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis. Arthritis Rheumatol. 2017 Apr; 69: (4)837-845.
    View PubMed
  12. Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA, Vasculitis Clinical Research Consortium. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis. Arthritis Rheumatol. 2017 Apr; 69: (4)846-853.
    View PubMed
  13. Zhang H, Watanabe R, Berry GJ, Vaglio A, Liao YJ, Warrington KJ, Goronzy JJ, Weyand CM. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis. Proc Natl Acad Sci U S A. 2017 Feb 07; 114: (6)E970-E979.
    View PubMed
  14. Koster MJ, Warrington KJ. Vasculitis of the mesenteric circulation. Best Pract Res Clin Gastroenterol. 2017 Feb; 31: (1)85-96.
    View PubMed
  15. Ungprasert P, Koster MJ, Warrington KJ, Matteson EL. Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies. Rheumatol Int. 2017 Jan; 37 (1):143-149 Epub 2016 Aug 30
    View PubMed
  16. Ungprasert P, Wijarnpreecha K, Koster MJ, Thongprayoon C, Warrington KJ. Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum. 2016 Dec; 46 (3):361-366 Epub 2016 July 21
    View PubMed
  17. Ungprasert P, Koster MJ, Thongprayoon C, Warrington KJ. Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Clin Rheumatol. 2016 Nov; 35 (11):2741-2747 Epub 2016 Aug 30
    View PubMed
  18. Chen JJ, Leavitt JA, Fang C, Crowson CS, Matteson EL, Warrington KJ. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis. Ophthalmology. 2016 Sep; 123 (9):1999-2003 Epub 2016 June 11
    View PubMed
  19. Jakobsson K, Jacobsson L, Mohammad AJ, Nilsson JA, Warrington K, Matteson EL, Turesson C. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis. BMC Musculoskelet Disord. 2016 Aug 24; 17 (1):363
    View PubMed
  20. Kermani TA, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McKinnon-Maksimowicz K, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Matteson EL, Vasculitis Clinical Research Consortium. The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. J Rheumatol. 2016 Jun; 43: (6)1078-84.
    View PubMed
  21. Kermani TA, Warrington KJ, Crowson CS, Hunder GG, Ytterberg SR, Gabriel SE, Matteson EL. Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis. J Clin Rheumatol. 2016 Jun; 22: (4)184-7.
    View PubMed
  22. Koster MJ, Matteson EL, Warrington KJ. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis. Curr Opin Rheumatol. 2016 May; 28: (3)211-7.
    View PubMed
  23. Koster MJ, Warrington KJ, Kermani TA. Update on the epidemiology and treatment of giant cell arteritis. Curr Treatm Opt Rheumatol.2016;2:138-152.
  24. Labarca C, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Warrington KJ. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford). 2016 Feb; 55: (2)347-56.
    View PubMed
  25. Labarca C, Makol A, Crowson CS, Kermani TA, Matteson EL, Warrington KJ. Retrospective Comparison of Open versus Endovascular Procedures for Takayasu Arteritis. J Rheumatol. 2016 Feb; 43: (2)427-32.
    View PubMed
  26. Ungprasert P, Upala S, Sanguankeo A, Warrington KJ. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis. Mod Rheumatol. 2016; 26: (3)410-4.
    View PubMed
  27. Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, Salvarani C, Matteson EL, Warrington KJ. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study. PLoS One. 2016; 11: (2)e0149579.
    View PubMed
  28. Koster MJ, Warrington KJ. Recent advances in understanding and treating vasculitis. F1000Res. 2016; 5:
    View PubMed
  29. Koster MJ, Warrington KJ. Recent advances in understanding and treating vasculitis [version 1; referees: 2 approved] F1000Research. 2016; 5:1436.
  30. Ungprasert P, Thongprayoon C, Warrington KJ. Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis. Ann Transl Med. 2015 Sep; 3: (16)232.
    View PubMed
  31. Kermani TA, Warrington KJ, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Seo P, Merkel PA, Ytterberg SR, Vasculitis Clinical Research Consortium. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. J Rheumatol. 2015 Jul; 42: (7)1213-7.
    View PubMed
  32. Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they? Semin Arthritis Rheum. 2015 Jun; 44: (6)724-8.
    View PubMed
  33. Bongartz T, Glazebrook KN, Kavros SJ, Murthy NS, Merry SP, Franz WB 3rd, Michet CJ, Veetil BM, Davis JM 3rd, Mason TG 2nd, Warrington KJ, Ytterberg SR, Matteson EL, Crowson CS, Leng S, McCollough CH. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015 Jun; 74: (6)1072-7.
    View PubMed
  34. Chandran AK, Udayakumar PD, Crowson CS, Warrington KJ, Matteson EL. The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009. Scand J Rheumatol. 2015 May; 44: (3)215-8.
    View PubMed
  35. Carmona FD, Mackie SL, Martin JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castaneda S, Cid MC, Hernandez-Rodriguez J, Prieto-Gonzalez S, Solans R, Ramentol-Sintas M, Gonzalez-Escribano MF, Ortiz-Fernandez L, Morado IC, Narvaez J, Miranda-Filloy JA, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schonau V, Franke A, Palm O, Molberg O, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, Gonzalez-Gay MA, Morgan AW, Martin J, Spanish GCA Group. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet. 2015 Apr 02; 96 (4):565-80 Epub 2015 Mar 26
    View PubMed
  36. Ungprasert P, Koster MJ, Warrington KJ. Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2015 Apr; 44 (5):586-591 Epub 2014 Oct 29
    View PubMed
  37. Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL. Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study. Arthritis Care Res (Hoboken). 2015 Mar; 67: (3)396-402.
    View PubMed
  38. Jakobsson K, Jacobsson L, Warrington K, Matteson EL, Liang K, Melander O, Turesson C. Body mass index and the risk of giant cell arteritis: results from a prospective study. Rheumatology (Oxford). 2015 Mar; 54: (3)433-40.
    View PubMed
  39. Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, Warrington KJ. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford). 2015 Mar; 54: (3)463-70.
    View PubMed
  40. Chandran A, Udayakumar PD, Kermani TA, Warrington KJ, Crowson CS, Matteson EL. Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009). Clin Exp Rheumatol. 2015 Mar-Apr; 33: (2 Suppl 89)S-98-102.
    View PubMed
  41. Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol. 2015 Feb; 42: (2)309-15.
    View PubMed
  42. Makol A, Matteson EL, Warrington KJ. Rheumatoid vasculitis: an update. Curr Opin Rheumatol. 2015 Jan; 27(1):63-70.
    View PubMed
  43. Renauer PA, Saruhan-Direskeneli G, Coit P, Adler A, Aksu K, Keser G, Alibaz-Oner F, Aydin SZ, Kamali S, Inanc M, Carette S, Cuthbertson D, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Langford CA, Maksimowicz-Mckinnon K, McAlear CA, Ozbalkan Z, Ates A, Karaaslan Y, Duzgun N, Monach PA, Ozer HTE, Erken E, Ozturk MA, Yazici A, Cefle A, Onat AM, Kisacik B, Pagnoux C, Kasifoglu T, Seyahi E, Fresko I, Seo P, Sreih AG, Warrington KJ, Ytterberg SR, Cobankara V, Cunninghame-Graham DS, Vyse TJ, Pamuk ON, Ercan Tunc S, Dalkilic E, Bicakcigil M, Yentur SP, Wren JD, Merkel PA, Direskeneli H, Sawalha AH. Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study. Arthritis and Rheumatology. 2015; 67(5):1361-8.
    View PubMed
  44. Ungprasert P, Thongprayoon C, Warrington KJ. Lower body mass index is associated with a higher risk of giant cell arteritis: A systematic review and meta-analysis Annals of Translational Medicine. 2015; 3: (16)232.
  45. Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study. J Rheumatol. 2014 Dec; 41: (12)2447-51.
    View PubMed
  46. Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford). 2014 May; 53: (5)890-9.
    View PubMed
  47. Krause ML, Lehman JS, Warrington KJ. Multicentric reticulohistiocytosis can mimic rheumatoid arthritis. J Rheumatol. 2014 Apr; 41(4):780-1.
    View PubMed
  48. Kermani TA, Warrington KJ. Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica. Ther Adv Musculoskelet Dis. 2014 Feb; 6: (1)8-19.
    View PubMed
  49. Ketha SS, Warrington KJ, McPhail IR. Inflammatory abdominal aortic aneurysm: a case report and review of literature. Vasc Endovascular Surg. 2014 Jan; 48: (1)65-9.
    View PubMed
  50. Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013 Dec; 72: (12)1989-94.
    View PubMed
  51. Chowdhary VR, Crowson CS, Bhagra AS, Warrington KJ, Vrtiska TJ. CT angiographic imaging characteristics of thoracic idiopathic aortitis. J Cardiovasc Comput Tomogr. 2013 Sep-Oct; 7: (5)297-302.
    View PubMed
  52. Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, Alibaz-Oner F, Kamali S, Inanc M, Carette S, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Langford CA, McAlear CA, Ozbalkan Z, Ates A, Karaaslan Y, Maksimowicz-McKinnon K, Monach PA, Ozer HT, Seyahi E, Fresko I, Cefle A, Seo P, Warrington KJ, Ozturk MA, Ytterberg SR, Cobankara V, Onat AM, Guthridge JM, James JA, Tunc E, Duzgun N, Bicakcigil M, Yentur SP, Merkel PA, Direskeneli H, Sawalha AH. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013 Aug 8; 93(2):298-305. Epub 2013 Jul 03.
    View PubMed
  53. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013 Aug; 88(8):822-30. Epub 2013 Jul 10.
    View PubMed
  54. Schmidt J, Kermani TA, Muratore F, Crowson CS, Matteson EL, Warrington KJ. Statin use in giant cell arteritis: a retrospective study. J Rheumatol. 2013 Jun; 40: (6)910-5.
    View PubMed
  55. Warrington KJ, Matteson EL. A primer on vasculitis. Minn Med. 2013 May; 96(5):36-9.
    View PubMed
  56. Skeik N, Rumery KK, Udayakumar PD, Crandall BM, Warrington KJ, Sullivan TM. Concurrent Takayasu arteritis with common variable immunodeficiency and moyamoya disease. Ann Vasc Surg. 2013 Feb; 27(2):240.e13-8.
    View PubMed
  57. Kermani TA, Warrington KJ. Polymyalgia rheumatica. Lancet. 2013 Jan 5; 381(9860):63-72. Epub 2012 Oct 08.
    View PubMed
  58. Akkara Veetil BM, Yee AH, Warrington KJ, Aksamit AJ Jr, Mason TG. Aseptic meningitis in adult onset Still's disease. Rheumatol Int. 2012 Dec; 32 (12):4031-4 Epub 2010 May 22
    View PubMed
  59. Kermani TA, Ham EK, Camilleri MJ, Warrington KJ. Polyarteritis nodosa-like vasculitis in association with minocycline use: a single-center case series. Semin Arthritis Rheum. 2012 Oct; 42(2):213-21. Epub 2012 Jun 15.
    View PubMed
  60. Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-alpha inhibitors. Mayo Clin Proc. 2012 Aug; 87: (8)739-45.
    View PubMed
  61. Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Hoffman GS, Merkel PA, Vasculitis Clinical Research Consortium. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis. 2012 Aug; 71(8):1329-34. Epub 2012 Feb 10.
    View PubMed
  62. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup. Arthritis Care Res (Hoboken). 2012 Jul; 64(7):1079-83.
    View PubMed
  63. Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012 Jun; 41: (6)866-71.
    View PubMed
  64. Makol A, Maleszewski JJ, Warrington KJ. A case of refractory rheumatoid pericarditis. Arthritis Care Res (Hoboken). 2012 Jun; 64: (6)935-40.
    View PubMed
  65. Makol A, Maleszewski JJ, Warrington KJ. , Maleszewski, JJ. Warrington, KJ “A Case of Refractory Rheumatoid Pericarditis” Arthritis Care Res (Hoboken). 2012 Jun; 64(6):935-40.
  66. Kermani TA, Warrington KJ. Recent advances in diagnostic strategies for giant cell arteritis. Curr Neurol Neurosci Rep. 2012 Apr; 12 (2):138-44
    View PubMed
  67. Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012 Feb; 39(2):303-9. Epub 2011 Dec 15.
    View PubMed
  68. Makol A, Parisi JE, Petty GW, Watson RE, Warrington KJ. A 60-year-old woman with headache, confusion, and hallucinations. Arthritis Care Res (Hoboken). 2011 Oct; 63(10):1486-94.
    View PubMed
  69. Schmidt J, Warrington KJ. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Drugs Aging. 2011 Aug 1; 28(8):651-66.
    View PubMed
  70. Kermani TA, Ytterberg SR, Warrington KJ. Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series. Arthritis Care Res (Hoboken). 2011 May; 63: (5)761-5.
    View PubMed
  71. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar; 63: (3)633-9.
    View PubMed
  72. Singh S, Michelena HI, Warrington KJ. The nails give it away. J Am Coll Cardiol. 2011 Feb 22; 57(8):996.
    View PubMed
  73. Kermani TA, Warrington KJ, Amin S. Malignancy risk in vasculitis. Ther Adv Musculoskelet Dis. 2011 Feb; 3: (1)55-63.
    View PubMed
  74. Piggott K, Deng J, Warrington K, Younge B, Kubo JT, Desai M, Goronzy JJ, Weyand CM. Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation. 2011 Jan 25; 123(3):309-18. Epub 2011 Jan 10.
    View PubMed
  75. Rieck KL, Kermani TA, Thomsen KM, Harmsen WS, Karban MJ, Warrington KJ. Evaluation for clinical predictors of positive temporal artery biopsy in giant cell arteritis. J Oral Maxillofac Surg. 2011 Jan; 69(1):36-40. Epub 2010 Jul 31.
    View PubMed
  76. Kermani TA, Warrington KJ. Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis. Curr Opin Rheumatol. 2011 Jan; 23: (1)38-42.
    View PubMed
  77. Salvarani C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV, Warrington KJ. Vasculitis of the gastrointestinal tract in chronic periaortitis. Medicine (Baltimore). 2011 Jan; 90(1):28-39.
    View PubMed
  78. Cohoon KP, Warrington KJ, Kalsi H. A 74-year-old female with acute vision loss and claudication; Interactive Case Study - October 2011. http://www.vascularmed.org/case_studies/case.cfm?id=281. 2011 Epub 2011 Oct.
  79. Schafer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study. Rheumatology (Oxford). 2010 Nov; 49: (11)2104-8.
    View PubMed
  80. Hoganson DD, Crowson CS, Warrington KJ, Gabriel SE, Matteson EL. Lack of association of high body mass index with risk for developing polymyalgia rheumatica. Int J Rheum Dis. 2010 Aug; 13: (3)e1-5.
    View PubMed
  81. Salvarani C, Calamia KT, Crowson CS, Miller DV, Broadwell AW, Hunder GG, Matteson EL, Warrington KJ. Localized vasculitis of the gastrointestinal tract: a case series. Rheumatology (Oxford). 2010 Jul; 49(7):1326-35. Epub 2010 Apr 01.
    View PubMed
  82. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ. Cancer preceding giant cell arteritis: a case-control study. Arthritis Rheum. 2010 Jun; 62: (6)1763-9.
    View PubMed
  83. Kermani TA, Warrington KJ. Images in vascular medicine. Isolated lower extremity vasculitis in a patient with polymyalgia rheumatica. Vasc Med. 2010 Apr; 15: (2)135-6.
    View PubMed
  84. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2010 Feb; 62: (2)149-54.
    View PubMed
  85. Saghir MK, Attenhofer Jost C, Warrington KJ, Cha SS, Pellikka PA. Exercise echocardiography in rheumatoid arthritis: a case-control study. J Am Soc Echocardiogr. 2009 Nov; 22: (11)1228-31.
    View PubMed
  86. Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, Matteson EL, Warrington KJ. Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol. 2009 Oct; 36: (10)2290-7.
    View PubMed
  87. Kermani TA, Matteson EL, Hunder GG, Warrington KJ. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol. 2009 Oct; 36(10):2277-83. Epub 2009 Sep 15.
    View PubMed
  88. Ytterberg SR, Warrington KJ, Daniel Aletaha, Thomas Bush. Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis. Joint Bone Spine. 2009 Jul; 76(4):440-3. Epub 2009 Jun 26.
    View PubMed
  89. Schafer VS, Warrington KJ, Williamson EE, Kermani TA. Delayed diagnosis of biopsy-negative giant cell arteritis presenting as fever of unknown origin. J Gen Intern Med. 2009 Apr; 24: (4)532-6.
    View PubMed
  90. Chowdhary VR, Crowson CS, Liang KP, Michet CJ Jr, Miller DV, Warrington KJ, Matteson EL. Cardiovascular risk factors and acute-phase response in idiopathic ascending aortitis: a case control study. Arthritis Res Ther. 2009; 11: (1)R29.
    View PubMed
  91. Warrington KJ, Jarpa EP, Crowson CS, Cooper LT, Hunder GG, Matteson EL, Gabriel SE. Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthritis Res Ther. 2009; 11: (2)R50.
    View PubMed
  92. Mennander AA, Miller DV, Liang KP, Warrington KJ, Connolly HM, Schaff HV, Sundt TM. Surgical management of ascending aortic aneurysm due to non-infectious aortitis. Scand Cardiovasc J. 2008 Dec; 42: (6)417-24.
    View PubMed
  93. Hoganson DD, Weenig RH, Warrington KJ. A 61-year-old man with livedo reticularis. Arthritis Rheum. 2008 Nov 15; 59(11):1682-4.
    View PubMed
  94. Postlethwaite AE, Wong WK, Clements P, Chatterjee S, Fessler BJ, Kang AH, Korn J, Mayes M, Merkel PA, Molitor JA, Moreland L, Rothfield N, Simms RW, Smith EA, Spiera R, Steen V, Warrington K, White B, Wigley F, Furst DE. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease. Arthritis Rheum. 2008 Jun; 58(6):1810-22.
    View PubMed
  95. Wilson FC, Warrington KJ. Pneumatosis intestinalis in limited scleroderma. J Rheumatol. 2008 Feb; 35: (2)352-3.
    View PubMed
  96. Warrington KJ, Matteson EL. Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol. 2007 Nov-Dec; 25: (6 Suppl 47)137-41.
    View PubMed
  97. Carbone LD, Warrington KJ, Barrow KD, Pugazhenthi M, Watsky MA, Somes G, Ingels J, Postlethwaite AE. Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles. Clin Exp Immunol. 2006 Dec; 146(3):371-80.
    View PubMed
  98. Warrington KJ, Nair U, Carbone LD, Kang AH, Postlethwaite AE. Characterisation of the immune response to type I collagen in scleroderma. Arthritis Res Ther. 2006; 8(4):R136.
    View PubMed
  99. Takagi K, Takagi M, Kanangat S, Warrington KJ, Shigemitsu H, Postlethwaite AE. Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways. J Immunol. 2005 Feb 15; 174(4):1801-10.
    View PubMed
  100. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ, Weyand CM. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther. 2005; 7: (5)R984-91.
    View PubMed
  101. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG, Mason TG, Nelson AM, Valente RM, Crowson CS, Erlich HA, Reynolds RL, Swee RG, O'Fallon WM, Weyand CM. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 2004 Jan; 50: (1)43-54.
    View PubMed
  102. Nuenninghoff DM, Warrington KJ, Matteson EL. Concomitant giant cell aortitis, thoracic aortic aneurysm, and aortic arch syndrome: occurrence in a patient and significance. Arthritis Rheum. 2003 Dec 15; 49(6):858-61.
    View PubMed
  103. Ahokas RA, Warrington KJ, Gerling IC, Sun Y, Wodi LA, Herring PA, Lu L, Bhattacharya SK, Postlethwaite AE, Weber KT. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. Circ Res. 2003 Nov 14; 93(10):e124-35. Epub 2003 Oct 23.
    View PubMed
  104. Weber KT, Sun Y, Wodi LA, Munir A, Jahangir E, Ahokas RA, Gerling IC, Postlethwaite AE, Warrington KJ. Toward a broader understanding of aldosterone in congestive heart failure. J Renin Angiotensin Aldosterone Syst. 2003 Sep; 4(3):155-63.
    View PubMed
  105. Gerling IC, Sun Y, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, Postlethwaite AE, Weber KT. Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol. 2003 Aug; 285(2):H813-21.
    View PubMed
  106. Weber KT, Gerling IC, Kiani MF, Guntaka RV, Sun Y, Ahokas RA, Postlethwaite AE, Warrington KJ. Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets. Curr Drug Targets. 2003 Aug; 4(6):505-16.
    View PubMed
  107. Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ. CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood. 2003 May 1; 101(9):3543-9.
    View PubMed
  108. Warrington KJ, Scheithauer BW, Michet CJ. Acute myeloid leukemia associated with necrotizing temporal arteritis. J Rheumatol. 2003 Apr; 30(4):846-8.
    View PubMed
  109. Cranmer LD, Warrington KJ, Ytterberg SR. 61-year-old man with dyspnea and bilateral foot drop. Mayo Clin Proc. 2002 Apr; 77(4):363-6.
    View PubMed
  110. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002 Feb 5; 105(5):570-5.
    View PubMed
  111. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum. 2001 Jan; 44(1):13-20.
    View PubMed
  112. Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc. 2000 May; 75(5):467-72.
    View PubMed